TickerFacts.

HCW Biologics Inc. (HCWB): Gross Profit

Annual figures by period end, from SEC filings.

$10.8K
Year ended 2025-12-31
$6.45M
Trailing 12 months to 2026-06-30
-83.9%
3-year compound annual growth
$2.59M2021-12-31: $02022-12-31: $2.59M2023-12-31: $560.4K2024-12-31: $959.4K2025-12-31: $10.8K$10.8K
2021-12-31 Gross Profit (USD) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31$10.8K-98.9%2026-03-31, From 2025-01-01
2024-12-31$959.4K+71.2%2026-03-31, From 2024-01-01
2023-12-31$560.4K-78.3%2025-03-28, From 2023-01-01
2022-12-31$2.59Mn/a2024-05-15, From 2022-01-01
2021-12-31$0n/a2023-03-28, From 2021-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
HCW Biologics Inc. (HCWB)2025-12-31$10.8K-98.9%
Silo Pharma, Inc. (SILO)2025-12-31$27.8K-58.0%
Impact Biomedical Inc. (IBO)2025-12-31-$392.0Kn/a
BullFrog AI Holdings, Inc. (BFRG)2025-12-31$21.9Kn/a
Jupiter Neurosciences, Inc. (JUNS)2025-12-31$17.6Kn/a
Skinvisible, Inc. (SKVI)2025-12-31$20.0K0.0%
Bioadaptives, Inc. (BDPT)2025-12-31$12.5K+210.1%
PRF Technologies Ltd. (PRFX)2025-12-31-$53.0Kn/a
Clene Inc. (CLNN)2025-12-31$157.0K-42.3%

Compare HCWB, SILO, IBO, BFRG side by side · Screen every company in Pharmaceutical Preparations ↗